These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32434)

  • 1. Effects of beta-adrenergic blocking agents on peripheral vascular resistance.
    Rascher W; Mann JF; Schömig A; Dietz R; Lüth JB
    Klin Wochenschr; 1978; 56 Suppl 1():87-90. PubMed ID: 32434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration and selectivity in beta-adrenoceptor blocking action of a beta-adrenoceptor blocking drug, D-32 in conscious dogs.
    Himori N; Honma S; Izumi A; Ishimori T
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Feb; 316(1):19-23. PubMed ID: 6116195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple method to determine the ratio of cardiac to vascular beta-receptor blockade in the rat in vivo.
    Kudo Y; Sokabe H; Zehr JE
    J Pharmacobiodyn; 1981 Jul; 4(7):475-82. PubMed ID: 6117611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β
    Lima AT; Amorim AC; Britto-Júnior J; Campitelli RR; Fregonesi A; Mónica FZ; Antunes E; De Nucci G
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1257-1268. PubMed ID: 35798982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central propranolol and pindolol, but not atenolol nor metoprolol, inhibit sexual behavior in male rats.
    Smith ER; Kacker SR; Raskin A; Yun PT; Davidson JM; Hoffman BB; Clark JT
    Physiol Behav; 1996 Feb; 59(2):241-6. PubMed ID: 8838601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
    Beaulieu G; Grimes D; Muirhead C; Oshiro G
    Can J Physiol Pharmacol; 1984 Jun; 62(6):610-6. PubMed ID: 6146394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of beta-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension.
    Tsukiyama H; Otsuka K; Miyamoto K; Hashimoto M; Yasutake S
    Jpn Circ J; 1976 Jun; 40(6):655-64. PubMed ID: 7688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenergic beta-receptorblockade: haemodynamic relevance of beta-1-selectivity and ISA during adrenaline infusion.
    Maltbaek N; Rehling M; Tangø M; Trap-Jensen J; Svendsen TL
    Acta Med Scand Suppl; 1983; 677():21-5. PubMed ID: 6142593
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
    Shulkin BL; Peele ME; Utiger RD
    Endocrinology; 1984 Sep; 115(3):858-61. PubMed ID: 6146516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
    Balasubramaniam S; Simons LA; Hickie JB; Chang S
    Artery; 1990; 17(2):60-70. PubMed ID: 1968740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers.
    Svendsen TL; Hartling O; Trap-Jensen J
    Eur J Clin Pharmacol; 1979 May; 15(4):223-8. PubMed ID: 38968
    [No Abstract]   [Full Text] [Related]  

  • 13. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.
    Hiatt WR; Wolfel EE; Stoll S; Nies AS; Zerbe GO; Brammell HL; Horwitz LD
    Clin Pharmacol Ther; 1985 Jan; 37(1):2-6. PubMed ID: 2856902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
    Riddell JG; Shanks RG
    Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
    Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct myocardial depressant effects of several beta-adrenergic blocking agents in the unanesthetized atherosclerotic rabbit.
    Lee RJ; Dickerson DD; Fulmor IE; Goldberg ME
    Proc Soc Exp Biol Med; 1978 Jun; 158(2):147-50. PubMed ID: 27818
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-adrenoceptor blockade by atenolol, metoprolol and propranolol in the anaesthetized cat.
    Lundgren B; Carlsson E; Herrmann I
    Eur J Pharmacol; 1979 May; 55(3):263-8. PubMed ID: 37096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of selective blockade of beta 2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model.
    Kroeger RJ; Groszmann RJ
    Gastroenterology; 1985 Apr; 88(4):896-900. PubMed ID: 2857673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term effects of beta blockers atenolol, nadolol, pindolol, and propranolol on lipoprotein metabolism in normolipemic subjects.
    Harvengt C; Heller FR; Martiat P; Van Nieuwenhuyze Y
    J Clin Pharmacol; 1987 Jul; 27(7):475-80. PubMed ID: 2888790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between beta-blockade, hyporeninaemic and hypotensive effect of two beta-blocking agents.
    Amery A; De Plaen JF; Fagard R; Linjen P; Reybrouck T
    Postgrad Med J; 1976; 52 Suppl 4():102-8. PubMed ID: 9626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.